The book provides an integrated survey of hematopoietic growth factors (HGFs) in oncology. It examines the role of HGFs in treating and preventing anemia, neutropenia, and thrombocytopenia in patients with both malignant and nonmalignant diseases. The text also offers insights into drug development and the translation of basic discoveries into clinical benefits.

This book is presented as a comprehensive and up-to-date resource for understanding the role of hematopoietic growth factors in oncology. It aims to bridge basic science with clinical practice, offering insights into treatment strategies and drug development. The content suggests a focus on practical applications for medical professionals and researchers in the field.